PC ruins the lives of millions…thanks a bunch, DSM writers!
In this editorial, Jennifer P. Schneider, MD, PhD, digs into a common—and frustrating—misunderstanding in pain medicine terminology.
FDA approved the buprenorphine implant, branded as Probuphine, in 2016 “for the maintenance treatment of opioid dependence.”
- Was it approved for the treatment of what we now call Opioid Use Disorder (OUD)?
- Or was the intent to approve it for physical dependence, a condition found in most opioid-treated chronic pain patients as well as opioid addicts?
It is not clear from the language.
View original post 1,108 more words